Elmiron Vision Loss Legal Options
Living with a chronic illness is difficult enough, but drugs can have major negative effects on some people. Elmiron, commonly known as pentosan polysulfate sodium (PPS), is the only FDA-approved oral drug for treating persistent bladder disease interstitial cystitis (IC). Unexpected side effects have been documented in women taking Elmiron to relieve the pain and suffering created by IC, including a newly found, degenerative eye illness that might result in irreversible loss of vision.
Side effects of Elmiron (PPS)
In November 2018, the Emory Eye Center published research that uncovered a unique and probably preventable maculopathy related to long-term exposure to PPS. Retinal pigmentary maculopathy, pattern dystrophy, and age-related macular degeneration are all common misdiagnoses for this recently found eye condition.
This warning triggered a more thorough investigation by the American Academy of Ophthalmology into the safety of Elmiron and its possible ocular toxicity. The disturbing findings of this study revealed that around a quarter of individuals who used Elmiron often revealed evidence of eye impairment.
The following are some of the most common indicators of Elmiron-related eye injury or visual complications:
- Adapting to variations in light is difficult.
- Straight lines that seem squiggly or wavy
- Vision blurring (usually in the center of the patient’s field of vision)
- Colors are muted and less vibrant.
- Find differences in the color of your eyes.
- Floaters, blind spots, or dark areas in the center of vision
If you or a loved one took Elmiron and were diagnosed with one of the following conditions, you may be eligible for compensation:
- Dry Macular Degeneration
- Pigmentation Maculopathy
- Retinal Maculopathy
- Retinal Pigmentary Endothelium Injury (RPE)
- Pigmentary Maculopathy
- Pigmentation Macular Degeneration
Background of Elmiron
Women are more likely to develop interstitial cystitis, which causes chronic discomfort in the bladder and pelvic. Elmiron was authorized by the FDA in 1996 to treat IC. It’s the only FDA-approved oral drug for the illness, which is thought to afflict around a million women in the United States.
Previously produced by Baker Norton Pharmaceuticals, Janssen Pharmaceuticals, Inc., a Johnson & Johnson affiliate, now owns and manufactures the medicine.
Until the drug’s label was updated in June 2020, the drug’s label did not include the possibility of irreversible vision loss or eye injury.
New Elmiron Eye Damage Lawsuits
New Elmiron lawsuits are being accepted by our Elmiron lawyers for victims seeking compensation. We’re searching for those who are experiencing side effects and match the following basic requirements.
You used Elmiron regularly for at least six months, and you had visual issues and were diagnosed with one of the following conditions:
- Macular retinopathy/maculopathy
- Macular degeneration
- Dystrophy of the retina
- Other retinal diseases
Elmiron Blindness Injury Attorney
For almost 40 years, the Willis Law Firm has pursued compensation for people hurt by dangerous drugs. David P. Willis is board certified as a personal injury trial law specialist. Our Elmiron attorneys in Houston assist patients and families around the United States, and we do it with unrivaled experience and success. Contact us at 713-654-4040 or 1-800-883-9858 to talk about your possible Elmiron vision loss claim.